{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:43:06Z","timestamp":1793511786070,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KG1816"],"award-info":[{"award-number":["01KG1816"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adenocarcinoma of the gastroesophageal junction (GEJ) Siewert type II can be resected by transthoracic esophagectomy or transhiatal extended gastrectomy. Both allow for a complete tumor resection, yet there is an ongoing controversy about which surgical approach is superior with regards to quality of life, oncological outcomes and survival. While some studies suggest a better oncological outcome after transthoracic esophagectomy, others favor transhiatal extended gastrectomy for a better postoperative quality of life. To date, only retrospective studies are available, showing ambiguous results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is a multinational, multicenter, randomized, clinical superiority trial. Patients (<jats:italic>n<\/jats:italic> = 262) with a GEJ type II tumor resectable by both transthoracic esophagectomy and transhiatal extended gastrectomy will be enrolled in the trial. Type II tumors are defined as tumors with their midpoint between \u22641\u2009cm proximal and \u2264 2\u2009cm distal of the top of gastric folds on preoperative endoscopy. Patients will be included in one of the participating European sites and are randomized to either transthoracic esophagectomy or transhiatal extended gastrectomy. The trial is powered to show superiority for esophagectomy with regards to the primary efficacy endpoint overall survival. Key secondary endpoints are complete resection (R0), number and localization of tumor infiltrated lymph nodes at dissection, post-operative complications, disease-free survival, quality of life and cost-effectiveness. Postoperative survival and quality of life will be followed-up for 24\u2009months after discharge. Further survival follow-up will be conducted as quarterly phone calls up to 60\u2009months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>To date, as level 1 evidence is lacking, there is no consensus on which surgery is superior and both surgeries are used to treat GEJ type II carcinoma worldwide. The CARDIA trial is the first randomized trial to compare transthoracic esophagectomy versus transhiatal extended gastrectomy in patients with GEJ type II tumors. Several quality control measures were implemented in the protocol to ensure data reliability and increase the trial\u2019s significance. It is hypothesized that esophagectomy allows for a higher rate of radical resections and a more complete mediastinal lymph node dissection, resulting in a longer overall survival, while still providing an acceptable quality of life and cost-effectiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The trial was registered on August 2nd 2019 at the German Clinical Trials Register under the trial-ID <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00016923\">DRKS00016923<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-07152-1","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T10:04:07Z","timestamp":1597917847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II"],"prefix":"10.1186","volume":"20","author":[{"given":"Jessica M.","family":"Leers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3501-5109","authenticated-orcid":false,"given":"Laura","family":"Knepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Zettelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A. A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle P.","family":"Ruurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane J.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"7152_CR1","unstructured":"Nederlandse Kankerregistratie. Cijfers over kanker. 2015. http:\/\/www.cijfersoverkanker.nl\/. Accessed June, 2016."},{"issue":"11","key":"7152_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1046\/j.1365-2168.1998.00940.x","volume":"85","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457\u20139.","journal-title":"Br J Surg."},{"issue":"3","key":"7152_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/gut.2009.186825","volume":"59","author":"KE McColl","year":"2010","unstructured":"McColl KE, Going JJ. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction\/cardia. Gut. 2010;59(3):282\u20134.","journal-title":"Gut."},{"key":"7152_CR4","unstructured":"Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Women\u2019s Hospital; Broad Institute; Brown University; Case Western Reserve University; Dana-Farber Cancer Institute; Duke University; Greater Poland Cancer Centre; Harvard Medical School; Institute for Systems Biology; KU Leuven; Mayo Clinic; Memorial Sloan Kettering Cancer Center; National Cancer Institute; Nationwide Children\u2019s Hospital; Stanford University; University of Alabama; University of Michigan; University of North Carolina; University of Pittsburgh; University of Rochester; University of Southern California; University of Texas MD Anderson Cancer Center; University of Washington; Van Andel Research Institute; Vanderbilt University; Washington University; Genome Sequencing Center: Broad Institute; Washington University in St. Louis; Genome Characterization Centers: BC Cancer Agency; Broad Institute; Harvard Medical School; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; University of North Carolina; University of Southern California Epigenome Center; University of Texas MD Anderson Cancer Center; Van Andel Research Institute; Genome Data Analysis Centers: Broad Institute; Brown University; Harvard Medical School; Institute for Systems Biology; Memorial Sloan Kettering Cancer Center; University of California Santa Cruz; University of Texas MD Anderson Cancer Center; Biospecimen Core Resource: International Genomics Consortium; Research Institute at Nationwide Children\u2019s Hospital; Tissue Source Sites: Analytic Biologic Services; Asan Medical Center; Asterand Bioscience; Barretos Cancer Hospital; BioreclamationIVT; Botkin Municipal Clinic; Chonnam National University Medical School; Christiana Care Health System; Cureline; Duke University; Emory University; Erasmus University; Indiana University School of Medicine; Institute of Oncology of Moldova; International Genomics Consortium; Invidumed; Israelitisches Krankenhaus Hamburg; Keimyung University School of Medicine; Memorial Sloan Kettering Cancer Center; National Cancer Center Goyang; Ontario Tumour Bank; Peter MacCallum Cancer Centre; Pusan National University Medical School; Ribeir\u00e3o Preto Medical School; St. Joseph\u2019s Hospital &Medical Center; St. Petersburg Academic University; Tayside Tissue Bank; University of Dundee; University of Kansas Medical Center; University of Michigan; University of North Carolina at Chapel Hill; University of Pittsburgh School of Medicine; University of Texas MD Anderson Cancer Center; Disease Working Group: Duke University; Memorial Sloan Kettering Cancer Center; National Cancer Institute; University of Texas MD Anderson Cancer Center; Yonsei University College of Medicine; Data Coordination Center: CSRA Inc.; Project Team: National Institutes of Health. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169\u2013175."},{"issue":"4","key":"7152_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ije\/29.4.645","volume":"29","author":"AA Botterweck","year":"2000","unstructured":"Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29(4):645\u201354.","journal-title":"Int J Epidemiol."},{"issue":"3","key":"7152_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","volume":"232","author":"JR Siewert","year":"2000","unstructured":"Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical\/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232(3):353\u201361.","journal-title":"Ann Surg."},{"issue":"6","key":"7152_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.amjsurg.2009.04.012","volume":"199","author":"JY An","year":"2010","unstructured":"An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Bae JM, et al. The prognosis of gastric cardia cancer after R0 resection. Am J Surg. 2010;199(6):725\u20139.","journal-title":"Am J Surg."},{"issue":"1","key":"7152_CR8","first-page":"1","volume":"30","author":"L Haverkamp","year":"2017","unstructured":"Haverkamp L, Seesing MF, Ruurda JP, Boone J, Hillegersberg RV. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus. 2017;30(1):1\u20137.","journal-title":"Dis Esophagus."},{"issue":"1","key":"7152_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10120-015-0466-3","volume":"19","author":"H Fuchs","year":"2016","unstructured":"Fuchs H, H\u00f6lscher AH, Leers J, Bludau M, Brinkmann A, Schr\u00f6der W, Alakus H, M\u00f6nig S, Gutschow C. Long term quality of life for surgery for adenocarcinoma of the gastroesophageal junction: extended gastrectomy or tranthoracic esophagectomy. Gastric Cancer. 2016;19(1):312\u20137.","journal-title":"Gastric Cancer."},{"issue":"4","key":"7152_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.suronc.2014.10.004","volume":"23","author":"L Haverkamp","year":"2014","unstructured":"Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R. Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol. 2014;23(4):222\u20138.","journal-title":"Surg Oncol."},{"issue":"9","key":"7152_CR11","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1046\/j.1365-2168.2002.02185.x","volume":"89","author":"C Mariette","year":"2002","unstructured":"Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg. 2002;89(9):1156\u201363.","journal-title":"Br J Surg."},{"issue":"suppl 5","key":"7152_CR12","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick F, Mariette C, Haustermans K, Obermannov\u00e1 R. Arnold D; ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v50\u20137.","journal-title":"Ann Oncol."},{"key":"7152_CR13","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"SE Al-Batran","year":"2016","unstructured":"Al-Batran SE, Hofheinz RD, Tannapfel A. Histopathologic regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucoverin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part from a multicenter, open label, randomized phase 2\/3 trial. Lancet Oncol. 2016;17:1697\u2013708.","journal-title":"Lancet Oncol."},{"issue":"2","key":"7152_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0040-6","volume":"14","author":"T Sano","year":"2011","unstructured":"Sano T, Kodera Y. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101\u201312.","journal-title":"Gastric Cancer."},{"issue":"1","key":"7152_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","volume":"14","author":"Japan Esophageal Society","year":"2017","unstructured":"Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th Edition: part I. Esophagus. 2017;14(1):1\u201336.","journal-title":"Esophagus."},{"key":"7152_CR16","unstructured":"[German S3-guideline \u201cDiagnosis and treatment of esophagogastric cancer\u201d]. Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, et al. AWMF; AWMF. Z Gastroenterol. 2011;49(4):461\u2013531."},{"issue":"2","key":"7152_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.athoracsur.2018.02.047","volume":"106","author":"B Schurink","year":"2018","unstructured":"Schurink B, Defize IL, Mazza E, Ruurda JP, Brosens LAA, Roeling TAP, et al. Two-Field Lymphadenectomy During Esophagectomy: The Presence of Thoracic Duct Lymph Nodes. Ann Thorac Surg. 2018;106(2):435\u20139.","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"7152_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/SLA.0000000000001098","volume":"262","author":"DE Low","year":"2015","unstructured":"Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, XB DJ, Griffin SM, H\u00f6lscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015;262(2):286\u201394.","journal-title":"Ann Surg."},{"key":"7152_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"issue":"2","key":"7152_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1245\/s10434-014-4047-1","volume":"22","author":"K Parry","year":"2015","unstructured":"Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R. Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol. 2015;22(2):597\u2013603.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"7152_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2307\/2531201","volume":"42","author":"JM Lachin","year":"1986","unstructured":"Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics. 1986;42(3):507\u201319.","journal-title":"Biometrics."},{"issue":"4","key":"7152_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Group C. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of internal medicine. 2008;148(4):295\u2013309.","journal-title":"Annals of internal medicine."},{"issue":"28","key":"7152_CR23","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1002\/sim.7057","volume":"35","author":"O Papachristofi","year":"2016","unstructured":"Papachristofi O, Klein A, Sharples L. Evaluation of the effects of multiple providers in complex surgical interventions. Statistics in medicine. 2016;35(28):5222\u201346.","journal-title":"Statistics in medicine."},{"key":"7152_CR24","doi-asserted-by":"crossref","unstructured":"Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246(1):1\u20138.","DOI":"10.1097\/01.sla.0000255563.65157.d2"},{"key":"7152_CR25","doi-asserted-by":"crossref","unstructured":"Leers JM, DeMeester SR, Chan N, Ayazi S, Oezcelik A, Abate E, Banki F, Lipham JC, Hagen JA, DeMeester TR. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg. 2009;138(3):594-602.","DOI":"10.1016\/j.jtcvs.2009.05.039"},{"key":"7152_CR26","doi-asserted-by":"crossref","unstructured":"C. Pedrazzani, M. Bernini, S. Giacopuzzi,\u00a0 Pugliese R, Catalano F, Festini M, Rodella L, de Manzoni G. Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: what is the role of endoscopic ultrasonography? J Surg Oncol. 2005;91(4):226\u2013231.","DOI":"10.1002\/jso.20302"},{"key":"7152_CR27","doi-asserted-by":"crossref","unstructured":"Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Offerhaus GJ, Ruurda JP, van Hillegersberg R. Staging of adenocarcinoma of the gastroesophageal junction. Eur J Surg Oncol. 2016;42(3):400\u20136.","DOI":"10.1016\/j.ejso.2015.11.014"},{"key":"7152_CR28","doi-asserted-by":"crossref","unstructured":"Rice TW, Patil DT, Blackstone EH. 8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119\u201330.","DOI":"10.21037\/acs.2017.03.14"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07152-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07152-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07152-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:30:49Z","timestamp":1629415849000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07152-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7152"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07152-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"To date, the study protocol has been approved by the ethics committee of the University of Cologne (reference number 19\u20131376), the University of Leipzig Medical Center (reference number 053\/20-lk), University Hospital rechts der Isar (reference number 57\/20\u2009S-HK), University Medical Center of the Johannes Gutenberg University Mainz (reference number 2020\u201314858) and the Medical Center \u2013 University of Freiburg (reference number 80\/20). The ethics committee of the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin does not require an additional ethics vote, after the study protocol has been approved by other German ethics boards. In case of important protocol modifications, the Principal Coordinating Investigator will inform the Principal Investigators of all trial sites. They will then forward the amendments to the associated ethics committees and trial participants.Written informed consent was and will be obtained from all participants. Investigators, Sub-Investigators and study nurses will be allowed to obtain informed consent.The following twelve centers were selected for participation in the CARDIA trial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LAAB is an Associate Editor for BMC Cancer. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"781"}}